Procter & Gamble Health Ltd - 500126 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Loss of Share Certificate / Issue of Duplicate Share Certificate.14-12-2019
14-12-2019
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by the shareholders, about the loss /misplacement of the share certificate as detailed in the attachment.28-11-2019
Procter & Gamble Health Ltd - 500126 - Updation Of Company''s And Investor''s Helpline Numbers
We would like to inform you that the Company''s Contact number and Investor''s helpline number have changed to 022-68669000 and 022-68669022 respectively. We request to take the same on record and update the same on the website of the Stock Exchange.14-11-2019
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by the shareholders, about the loss /misplacement of the share certificate as detailed in the attachment.11-11-2019
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agent, Karvy Fintech Private Limited about the issue of duplicate share certificates as detailed in the attachment.07-11-2019
Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended September 30, 2019
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended September 30, 2019 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2019; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2019 furnished by Statutory Auditors of the Company; and Kindly take the same on record and oblige.07-11-2019
Procter & Gamble Health Ltd - 500126 - Outcome of Board Meeting
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended September 30, 2019 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2019; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2019 furnished by Statutory Auditors of the Company; and Kindly take the same on record and oblige.07-11-2019
Procter & Gamble Health Ltd - 500126 - Revision of Board Meeting
Purpose of the meeting has been revised30-10-2019
Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Period Ended September 30, 2019 And Declaration Of Interim Dividend, If Any.
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2019 ,inter alia, to consider and approve the financial results for the period ended September 30, 2019 and declaration of interim dividend, if any.28-10-2019
Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended September 30, 2019
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here22-10-2019